Free EU shipping over €150·Discreet tracked delivery·Fresh stock just landed · shop now
PepsupResearch Peptides
10 Jul 2026

MOTS-c, 5-Amino-1MQ and the AMPK/NAD+ Axis

Nicotinamide adenine dinucleotide (NAD+) is an indispensable coenzyme for ATP production and DNA repair, and it crashes as cells age. Two research compounds dominate the bench work built around that crash: MOTS-c and 5-Amino-1MQ. This guide sets out how each engages the AMPK and NAD+ axes, which in vitro models suit them, and how they compare side by side, along with the purity and handling factors that decide whether your assay data means anything at all.

Cellular ageing as an energy crisis

From an analytical standpoint, cellular ageing reads as a progressive energy crisis: mitochondrial function declines as coenzyme pools fall, and the downstream picture in model systems is tissue fatigue and broad metabolic dysfunction.

That leaves two logically distinct points of intervention in an experimental design. You can act on mitochondrial genomics and the signalling peptides encoded there, or you can act on the cytoplasmic enzymes that control how fast NAD+ gets consumed and recycled. MOTS-c represents the first strategy, 5-Amino-1MQ the second, and both converge on the same readouts: mitochondrial respiration and substrate oxidation.

MOTS-c: a peptide encoded by the mitochondrial genome

Most metabolic peptides come from nuclear DNA. MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) does not. It sits directly inside the mitochondrial genome, which makes it an unusual object of study: a signalling molecule that works as an intracellular energy gauge and, at system level, as a metabolic regulator.

Activation of the AMPK energy-sensing pathway

When cellular energy levels drop, MOTS-c moves to the nucleus and directly regulates adaptive nuclear gene expression. In skeletal muscle assays it activates AMP-activated protein kinase (AMPK), which raises glucose uptake and fatty acid oxidation independently of insulin signalling. That retrograde route, from mitochondrion to nucleus, is what makes the peptide valuable as a mechanistic probe rather than just another metabolic agonist.

MOTS-c is highly sensitive to environmental degradation, so verifying synthesis purity by HPLC is non-negotiable before it goes into a kinase assay.

AMPK activation in skeletal muscle glucose disposal assays

Biochemists universally treat AMPK as the master cellular energy sensor, which is why so much metabolic screening work funnels through it. Mapping how peptides such as MOTS-c, and advanced incretin mimetics, stimulate AMPK in skeletal muscle cells is central to tracing glucose disposal pathways that skip insulin altogether.

Bypassing insulin resistance in vitro

When metabolic signalling peptides phosphorylate AMPK in myotube assays, the cascade that follows drives GLUT4 vesicle translocation to the sarcolemma. In practice, that means skeletal muscle cells clear glucose from culture media even when lipotoxicity has completely blocked insulin receptor signalling.

Because these endpoints show up as phosphorylation states, contaminant peptides and truncated sequences are not a cosmetic problem. They shift the baseline of the very signal you are trying to measure.

5-Amino-1MQ: blocking NNMT to protect NAD+ salvage

Small molecule inhibitors and peptide-derived metabolic modulators cross paths constantly in modern biochemistry, and 5-Amino-1MQ is a clean example. It is a targeted, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme expressed mainly in white adipose tissue that sits at a control point of cellular energy balance.

Block NNMT in adipocyte assays and 5-Amino-1MQ stops the methylation of nicotinamide into 1-methylnicotinamide. Nicotinamide gets recycled instead of exported as a methylated dead end. Intracellular NAD+ pools stay intact, the NAD+ salvage pathway runs harder, and SIRT1 activity climbs, which in these models drives rapid adipose tissue oxidation and smaller adipocyte size.

Why NAD+ availability governs the whole system

NAD+ is not just a redox carrier. In laboratory models, keeping NAD+ pools at their optimum is what lets sirtuins (the so-called longevity genes) and PARP enzymes, which detect and repair DNA strand breaks, operate at all. Pairing NAD+ work with signalling peptides creates a setting for studying cellular rejuvenation and metabolic recovery together, rather than one isolated pathway at a time.

This is why NAD+ tooling sits inside the wider longevity research range rather than off in its own silo. Sirtuin and PARP experiments sit downstream of coenzyme availability, so you have to control the coenzyme axis first.

MOTS-c and 5-Amino-1MQ compared

Designing an experimental model of cellular energy metabolism usually comes down to a choice: target mitochondrial genomics, or target cytoplasmic enzyme inhibition. These two compounds map onto those strategies cleanly.

ParameterMOTS-c5-Amino-1MQ
ClassMitochondrial-derived signalling peptideSmall molecule enzyme inhibitor
OriginEncoded within the mitochondrial genome (12S rRNA-c reading frame)Synthetic, membrane-permeable
Site of actionMitochondrion to nucleus, endocrine-like signallingCytoplasm, principally white adipose tissue
Primary targetAMPK activation and nuclear gene expressionNNMT inhibition
Downstream effectGlucose uptake and fatty acid oxidation independent of insulinPreserved NAD+ pools and elevated SIRT1 activity
Best-suited modelSimulating endurance exercise pathways in skeletal muscleReversing adipocyte hypertrophy and NAD+ decline
Typical readoutsPhospho-AMPK, GLUT4 translocation, glucose clearance from media, mitochondrial densityIntracellular NAD+ quantification, respiration rate, adipocyte size

The two are not interchangeable, and they are not strictly competing either. MOTS-c raises the energy-sensing signal; 5-Amino-1MQ protects the coenzyme pool that the resulting oxidative work depends on. Groups modelling metabolic recovery often run both arms in parallel, with single-agent controls in each case, to separate signalling effects from substrate availability and still attribute a combined result properly.

Purity, degradation and experimental validity

Both compounds need exceptional purity to avoid cellular toxicity in sensitive assays, and MOTS-c in particular tolerates poor handling badly. Degraded coenzymes or impure peptide reagents ruin a promising metabolic experiment faster than any design flaw, because the artefact looks exactly like a result.

Our position on this is simple. Many vendors put a large share of their margin into affiliate marketing. We put that budget into independent European HPLC and mass spectrometry verification instead, at over €200 per batch. Stock ships from an EU warehouse, which keeps transit short and avoids the customs delays and heat exposure that quietly degrade sensitive reagents on long transcontinental routes.

If you are building a mitochondrial or NAD+ workflow, fix the variables you can control first: verified sequence identity, documented purity, aliquoted stock to avoid repeated freeze-thaw cycles, and batch numbers logged against every arm of the experiment. The full range of metabolic, mitochondrial and longevity compounds is in our shop, each dispatched from EU stock with a batch-specific certificate of analysis.

All products supplied by Pepsup are for laboratory research use only. Not for human or veterinary consumption, and not for diagnostic or therapeutic use.

← All posts